Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 11, 2008, Pages 752-760

  El Midaoui, Adil ^a   Ismael, Mahmoud Ali ^b   Lu, Huogen ^a   Fantus, I George ^a   De Champlain, Jacques ^b   Couture, Réjean ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ACE inhibitor; Hypertension, insulin resistance; N acetyl L cysteine; Oxidative stress; Ramipril

Indexed keywords

ACETYLCYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; RAMIPRIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACETYLCYSTEINE; ALDEHYDES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DIET; FREE RADICAL SCAVENGERS; GLUCOSE; HYPERTENSION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MUSCLE, SKELETAL; NADPH OXIDASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RAMIPRIL; RATS; RATS, WISTAR;

EID: 56449116133     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-090     Document Type: Article

References (50)

1. Asahi, K., Ichimori, K., Nakazawa, H., Izuhara, Y., Inagi, R., Watanabe, T., et al. 2000. Nitric oxide inhibits the formation of advanced glycation end products. Kidney Int. 58(4): 1780-1787. PMID:11012913.
2. Bertrand, M.E. 2004. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr. Med. Res. Opin. 20: 1559-1569. doi:10.1185/030079904X4185. PMID:15462689.
3. Busse, E., Zimmer, G., Schopohl, B., and Kornhuber, B. 1992. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung, 42: 829-831. PMID: 1418040.
4. Cabassi, A., Bouchard, J.F., Dumont, E.C., Girouard, H., LeJossec, M., Lamontagne, D., et al. 2000. Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats. J. Hypertens. 18: 187-196. doi:10.1097/00004872-200018020-00009. PMID:10694187.
5. Cabassi, A., Dumont, E.C., Girouard, H., Bouchard, J.F., LeJossec, M., Lamontagne, D., et al. 2001. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J. Hypertens. 19: 1233-1244. doi:10.1097/00004872- 200107000-00008. PMID:11446713.
6. Cai, H., Griendling, K.K., and Harrison, D.G. 2003. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24: 471-478. doi:10.1016/S0165-6147(03)00233-5. PMID:12967772.
7. Couture, R., and Girolami, J.P. 2004. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur. J. Pharmacol. 500: 467-485. doi:10.1016/j.ejphar. 2004.07.045. PMID:15464053.
8. De Vries, N., and De Flora, S. 1993. N-Acetyl-L-cysteine. J. Cell. Biochem. Suppl. 17F: 270-277. doi:10.1002/jcb.240531040. PMID:8412205.
9. 1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance. Br. J. Pharmacol. 152: 280-287. doi:10.1038/sj.bjp. 0707388. PMID:17618300.
10. Dimitropoulou, C., Chatterjee, A., McCloud, L., Yetik-Anacak, G., and Catravas, J.D. 2006. Angiotensin, bradykinin and the endothelium. Handb. Exp. Pharmacol. 176(Pt 1): 255-294. doi:10.1007/3-540-32967-6_8. PMID:16999222.
11. Diniz, Y.S., Rocha, K.K., Souza, G.A., Galhardi, C.M., Ebaid, G.M., Rodrigues, H.G., et al. 2006. Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur. J. Pharmacol. 543: 151-157. doi:10.1016/j.ejphar.2006.05.039. PMID:16814277.
12. El Midaoui, A., and de Champlain, J. 2002. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid. Hypertension, 39: 303-307. doi:10.1161/hy0202.104345. PMID:11847202.
13. El Midaoui, A., Ongali, B., Petcu, M., Rodi, D., de Champlain, J., Neugebauer, W., and Couture, R. 2005. Increases of spinal kinin receptor binding sites in two rat models of insulin resistance. Peptides, 26: 1323-1330. doi:10.1016/j.peptides.2005.03.028. PMID:16042974.
14. El Midaoui, A., Lungu, C., Wu, L., Robillard, C., deBlois, D., Couture, R., et al. 2006. Effects of alpha-lipoic acid on superoxide anion production and peroxisome proliferator-activated receptor-a expression in liver tissue in chronically hypertensive insulin-resistant rats. Exp. Clin. Cardiol. 11: 30. [Abstr.]
15. Forbes, J.M., Cooper, M.E., Thallas, V., Burns, W.C., Thomas, M.C., Brammar, G.C., et al. 2002. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes, 51: 3274-3282. doi:10.2337/diabetes.51.11.3274. PMID:12401719.
16. Giorgino, F., Logoluso, F., Davalli, A.M., Napoli, R., Laviola, L., Hirshman, M.F., et al. 1999. Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats. Diabetes, 48: 801-812. doi:10.2337/diabetes.48.4.801. PMID:10102697.
17. Girouard, H., Chulak, C., LeJossec, M., Lamontagne, D., and de Champlain, J. 2003. Chronic antioxidant treatment improves sympathetic functions and β-adrenergic pathway in the spontaneously hypertensive rats. J. Hypertens. 21: 179-188. doi:10.1097/00004872-200301000-00028. PMID:12544450.
18. Giugliano, D., Ceriello, A., and Paolisso, G. 1995. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism, 44: 363-368. doi:10.1016/0026-0495(95)90167-1. PMID:7885282.
19. Henriksen, E.J., Jacob, S., Augustin, H.J., and Dietze, G.J. 1996. Glucose transport activity in insulin-resistant rat muscle: effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism. Diabetes, 45: S125-S128. PMID:8529793.
20. Ho, E., Chen, G., and Bray, T.M. 1999. Supplementation of N-acetylcysteine inhibits NF-kappa B activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J. 13: 1845-1854. PMID:10506589.
21. Hwang, I.S., Ho, H., Hoffman, B.B., and Reaven, G.M. 1987. Fructose-induced insulin resistance and hypertension in rats. Hypertension, 10: 512-516. PMID:3311990.
22. Inoguchi, T., and Nawata, H. 2005. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr. Drug Targets, 6: 495-501. doi:10.2174/1389450054021927. PMID:16026268.
23. 1 receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Eur. J. Pharmacol. 589: 66-72. doi:10.1016/j.ejphar.2008.05.006. PMID:18555989.
24. Jacob, S., Streeper, R.S., Fogt, D.L., Hokama, J.Y., Tritschler, H.J., Dietze, G.J., and Henriksen, E.J. 1996. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes, 45: 1024-1029. doi:10.2337/diabetes.45.8.1024. PMID:8690147.
25. Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., et al. 1999. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes, 48: 2398-2406. doi:10.2337/diabetes.48.12.2398. PMID:10580429.
26. Kashiwagi, A., Shinozaki, K., Nishio, Y., Okamura, T., Toda, N., and Kikkawa, R. 1999. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state. Diabetes Res. Clin. Pract. 45: 199-203. doi:10.1016/S0168-8227(99)00062-5. PMID:10588373.
27. Kerr, S., Brosnan, M.J., McIntyre, M., Reid, J.L., Dominiczak, A.F., and Hamilton, C.A. 1999. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension, 33: 1353-1358. PMID:10373215.
28. Kishi, K., Muromoto, N., Nakaya, Y., Miyata, I., Hagi, A., Hayashi, H., and Ebina, Y. 1998. Bradykinin directly triggers GLUT 4 translocation via an insulin independent pathway. Diabetes, 47(4): 550-558. doi:10.2337/diabetes.47.4.550. PMID:9568686.
29. Landmesser, U., and Drexler, H. 2006. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide. J. Hypertens. 24(Suppl.): S39-S43. doi:10.1097/01.hjh.0000220405. 38622.23.
30. Linz, W., Wiemer, G., Gohlke, P., Unger, T., and Schölkens, B.A. 1995. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47(1): 25-49. PMID:7784479.
31. Linz, W., Jessen, T., Becker, R.H., Schölkens, B.A., and Wiemer, G. 1997. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation, 96(9): 3164-3172. PMID:9386189.
32. 1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance. Neuropeptides, 41: 375-387. PMID:17988733.
33. Luo, X.P., Yazdanpanah, M., Bhooi, N., and Lehotay, D.C. 1995. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal. Biochem. 228: 294-298. doi:10.1006/abio.1995.1353.
34. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412-419. doi:10.1007/BF00280883. PMID:3899825.
35. McFarlane, S.I., Kumar, A., and Sowers, J.R. 2003. Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am. J. Cardiol. 91: 30H-37H. doi:10.1016/S0002-9149(03)00432-6. PMID:12818733.
36. Midaoui, A.E., Elimadi, A., Wu, L., Haddad, P.S., and de Champlain, J. 2003. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am. J. Hypertens. 16: 173-179. doi:10.1016/S0895-7061(02)03253-3. PMID:12620694.
37. Mikrut, K., Paluszak, J., Kólik, J., Sosnowski, P., Krauss, H., and Grzékowiak, E. 2001. The effect of bradykinin on the oxidative state or rats with acute hyperglycaemia. Diabetes Res. Clin. Pract. 51: 79-85. doi:10.1016/S0168-8227(00)00222-9. PMID:11165687.
38. Munzel, T., Sayegh, H., Freeman, B.A., Tarpey, M.M., and Harrison, D.G. 1995. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95: 187-194. doi:10.1172/JCI117637. PMID:7814613.
39. Ohara, Y., Peterson, T.E., and Harrison, D.G. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91: 2546-2551. doi:10.1172/JCI116491. PMID:8390482.
40. Portero-Otin, M., Pamplona, R., Boada, J., Jové, M., Gonzalo, H., Buleon, M., et al. 2008. Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochem. Biophys. Res. Commun. 368: 528-535. doi:10.1016/j.bbrc.2008.01.101. PMID:18243127.
41. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K., and Harrison, D.G. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97: 1916-1923. doi:10.1172/JCI118623. PMID:8621776.
42. Song, D., Hutchings, S., and Pang, C.C.Y. 2005. Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eur. J. Pharmacol. 508: 205-210. doi:10.1016/j.ejphar.2004.12.018. PMID:15680273.
43. Sonta, T., Inoguchi, T., Tsubouchi, H., Sekiguchi, N., Kobayashi, K., Matsumoto, S., et al. 2004. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic. Biol. Med. 37: 115-123. doi:10.1016/j.freeradbiomed.2004.04. 001. PMID:15183199.
44. Suzuki, H., Swei, A., Zweifach, B.W., and Schmid-Schonbein, G.W. 1995. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension, 25: 1083-1089. PMID:7737720.
45. Tanaka, Y., Gleason, C.E., Tran, P.O., Harmon, J.S., and Robertson, R.P. 1999. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl. Acad. Sci. U.S.A. 96: 10857-10862. doi:10.1073/pnas.96.19.10857. PMID:10485916.
46. Tesfamariam, B. 1994. Free radicals in diabetic endothelial cell dysfunction. Free Radic. Biol. Med. 16(3): 383-391. doi:10.1016/0891- 5849(94)90040-X. PMID:8063201.
47. Vasdev, S., Ford, C.A., Parai, S., Longerich, L., and Gadag, V. 2000. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J. Hypertens. 18: 567-573. doi:10.1097/00004872- 200018050-00009. PMID:10826559.
48. Villafana, S., Huang, F., and Hong, E. 2004. Role of the sympathetic and renin angiotensin systems in the glucose-induced increase of blood pressure in rats. Eur. J. Pharmacol. 506: 143-150. doi:10.1016/j.ejphar.2004.10.055. PMID:15588734.
49. Wu, R., Millette, E., Wu, L., and de Champlain, J. 2001. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and deoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 19: 741-748. doi:10.1097/00004872-200104000-00011. PMID:11330877.
50. 1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients. J. Renin Angiotensin Aldosterone Syst. 4: 197-203. doi:10.3317/jraas.2003.032. PMID:14608527.